(Q52203787)

27 April 2018

title

Devazepide, a CCKA receptor antagonist, impairs the acquisition of conditioned reward and conditioned activity. (English)

1 reference

27 April 2018

1

S A Josselyn

1 reference

27 April 2018

author name string

V P Franco

series ordinal

2

1 reference

27 April 2018

F J Vaccarino

series ordinal

3

1 reference

27 April 2018

publication date

1 January 1996

1 reference

27 April 2018

published in

Psychopharmacology

1 reference

27 April 2018

volume

123

1 reference

27 April 2018

issue

2

1 reference

27 April 2018

page(s)

131-143

1 reference

27 April 2018

https://scigraph.springernature.com/pub.10.1007/bf02246170

exact match

0 references

cites work

The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokinin

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02246170

A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing

21 January 2018

1 reference

12 December 2020

Blockade of morphine place conditioning by the CCKA receptor antagonist devazepide.

1 reference

12 December 2020

Peptide-monoamine coexistence: Studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons

1 reference

12 December 2020

Evidence for the contribution of CCKB receptor mechanisms to individual differences in amphetamine-induced locomotion

1 reference

12 December 2020

Cholecystokinin-dopamine interactions within the nucleus accumbens in the control over behaviour by conditioned reinforcement

1 reference

12 December 2020

Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function

1 reference

12 December 2020

The CCKA receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: comparison with the dopamine antagonist haloperidol

1 reference

12 December 2020

Cholecystokinin antagonist lorglumide reverses chronic haloperidol-induced effects on dopamine neurons

1 reference

12 December 2020

Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms.

1 reference

12 December 2020

Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors

1 reference

12 December 2020

Coexistence of neuronal messengers--an overview

1 reference

12 December 2020

Two brain cholecystokinin receptors: implications for behavioral actions

1 reference

12 December 2020

The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine

1 reference

12 December 2020

Potency of L-364,718 as an antagonist of the behavioral effects of peripherally administered cholecystokinin.

1 reference

12 December 2020

Effects of selective drugs for dopaminergic D1 and D2 receptors on conditioned locomotion in rats.

1 reference

12 December 2020

Distribution of cholecystokinin-like immunoreactivity in the rat main olfactory bulb

1 reference

12 December 2020

The CCK-A receptor antagonist devazepide but not the CCK-B receptor antagonist L-365,260 reverses the effects of chronic clozapine and haloperidol on midbrain dopamine neurons

1 reference

12 December 2020

Cholecystokinin innervation of the ventral striatum: a morphological and radioimmunological study

1 reference

12 December 2020

Learned taste aversions in rats as a function of dosage, concentration, and route of administration of LiCl.

1 reference

12 December 2020

Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat.

1 reference

12 December 2020

Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression

1 reference

12 December 2020

The effect of pimozide on the establishment of conditioned reinforcement.

1 reference

12 December 2020

Failure of cholecystokinin antagonists to modify the discriminative stimulus effects of cocaine

1 reference

12 December 2020

Enhanced behavioural control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens.

1 reference

12 December 2020

The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay

1 reference

12 December 2020

The distribution and some connections of cholecystokinin neurons in the rat brain

1 reference

12 December 2020

Immunochemical evidence of cholecystokinin-like peptides in brain

1 reference

12 December 2020

Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway

1 reference

12 December 2020

Distinct cholecystokinin receptors in brain and pancreas

1 reference

12 December 2020

Effects of CS-US interval on conditioning of drug response, with assessment of speed of conditioning

1 reference

12 December 2020

Neuronal localization of cholecystokinin mRNA in the rat brain by using in situ hybridization histochemistry

1 reference

12 December 2020

Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning.

1 reference

12 December 2020

Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist

1 reference

12 December 2020

The effects of pimozide on the establishment of conditioned reinforcement as a function of the amount of conditioning

1 reference

12 December 2020

Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists

1 reference

12 December 2020

Receptor subtype-specific dopaminergic agents and conditioned behavior

1 reference

12 December 2020

Interaction of CCKB receptors with amphetamine in responding for conditioned rewards.

1 reference

12 December 2020

Effects of cholecystokinin antagonists on the discriminative stimulus effects of cocaine in rats and monkeys

1 reference

12 December 2020

Biological actions of cholecystokinin

1 reference

12 December 2020

Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons

1 reference

12 December 2020

Does cholecystokinin potentiate dopamine action in the nucleus accumbens?

1 reference

12 December 2020

New peptide in the vertebrate CNS reacting with antigastrin antibodies

1 reference

12 December 2020

Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide

1 reference

12 December 2020

A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260

1 reference

12 December 2020

Evidence for an endogenous cholecystokininergic balance in social memory

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02246170

1 reference

27 April 2018

1 reference

27 April 2018